180 related articles for article (PubMed ID: 29407362)
1. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.
Blue SW; Winchell AJ; Kaucher AV; Lieberman RA; Gilles CT; Pyra MN; Heffron R; Hou X; Coombs RW; Nanda K; Davis NL; Kourtis AP; Herbeck JT; Baeten JM; Lingappa JR; Erikson DW
Contraception; 2018 Apr; 97(4):363-369. PubMed ID: 29407362
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous assay of segesterone acetate (Nestorone®), estradiol, progesterone, and estrone in human serum by LC-MS/MS.
Erikson DW; Blue SW; Fecteau KM; Edelman AB; Jensen JT; Blithe DL
Contraception; 2020 Nov; 102(5):361-367. PubMed ID: 32828731
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry.
Knezevic CE; Parsons TL; Gollings R; Pandey A; Marzinke MA
J Pharm Biomed Anal; 2023 May; 228():115321. PubMed ID: 36924631
[TBL] [Abstract][Full Text] [Related]
4. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
Aden U; Jung-Hoffmann C; Kuhl H
Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
[TBL] [Abstract][Full Text] [Related]
5. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of levonorgestrel and two endogenous sex hormones in human plasma based on LC-MS/MS.
Wang R; Tian Y; Zhang L; Zhang Z
Bioanalysis; 2016 Jun; 8(11):1133-44. PubMed ID: 27211854
[TBL] [Abstract][Full Text] [Related]
7. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Rossmanith WG; Steffens D; Schramm G
Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
[TBL] [Abstract][Full Text] [Related]
8. Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
Jensen JT; Edelman A; Westhoff CL; Schreiber CA; Archer DF; Teal S; Thomas M; Brown J; Blithe DL
Contraception; 2024 Apr; ():110475. PubMed ID: 38670302
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
el-Raghy I; Back DJ; Makeram M; Salem H; Osman F; Fathalla M; Orme ML
Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
[TBL] [Abstract][Full Text] [Related]
10. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
Pyra M; Lingappa JR; Heffron R; Erikson DW; Blue SW; Patel RC; Nanda K; Rees H; Mugo NR; Davis NL; Kourtis AP; Baeten JM;
Contraception; 2018 Apr; 97(4):357-362. PubMed ID: 29408422
[TBL] [Abstract][Full Text] [Related]
11. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
[TBL] [Abstract][Full Text] [Related]
12. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
Joshi JV; Sankolli GM; Shah RS; Joshi UM
Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole does not affect the bioavailability of oral contraceptives.
Fuchs W; Sennewald R; Klotz U
Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
Bowles SM; Mills RJ
Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
16. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
18. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
20. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
Landgren BM; Diczfalusy E
Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
